Exelixis, Inc. News Releasehttp://phx.corporate-ir.net/phoenix.zhtml?c=120923&p=irol-news&nyo=0A Collection of Exelixis, Inc. News Releaseen-usUncategorizedFri, 14 Jun 2013 15:52:30 GMTExelixis Announces Webcasts of Upcoming Investor Conference Presentationshttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1827444Uncategorized1827444_NEWSWed, 05 Jun 2013 20:05:23 GMTExelixis Presents COMETRIQ™ (cabozantinib) Clinical Trial Data in Patients with Progressive, Metastatic Medullary Thyroid Cancerhttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1826062Uncategorized1826062_NEWSSun, 02 Jun 2013 13:00:37 GMTExelixis Announces Presentation of Updated Phase 2 Data for Cabozantinib in Men with Heavily-Pretreated Metastatic Castration-Resistant Prostate Cancerhttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1826047Uncategorized1826047_NEWSSat, 01 Jun 2013 13:00:32 GMTExelixis Initiates Phase 3 Pivotal Trial of Cabozantinib in Patients With Metastatic Renal Cell Carcinomahttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1825803Uncategorized1825803_NEWSFri, 31 May 2013 10:00:17 GMTReminder: Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meetinghttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1820612Uncategorized1820612_NEWSWed, 15 May 2013 20:02:45 GMTExelixis Announces Webcasts of Upcoming Investor Conference Presentationshttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1817399Uncategorized1817399_NEWSWed, 08 May 2013 21:42:11 GMTExelixis Announces First Quarter 2013 Financial Resultshttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1816668Uncategorized1816668_NEWSTue, 07 May 2013 20:15:53 GMTCabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meetinghttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1816652Uncategorized1816652_NEWSTue, 07 May 2013 20:13:47 GMTExelixis Announces May 7th Webcast of First Quarter 2013 Financial Results Conference Callhttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1807939Uncategorized1807939_NEWSWed, 17 Apr 2013 22:13:04 GMTPreclinical Data Presented at AACR Describe a Mechanism of Action of Cabozantinib in a Prostate Cancer Bone Metastasis Modelhttp://ir.exelixis.com/phoenix.zhtml?c=120923&p=RssLanding&cat=news&id=1804887Uncategorized1804887_NEWSTue, 09 Apr 2013 20:01:34 GMT